During the past decade, California Spine Diagnostics conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "California Spine Diagnostics" are "Degenerative Disc Disease" (2 trials), "Back Pain" (1 trials), "Chronic Low Back Pain" (1 trials) and "Internal Disc Disruption" (1 trials). Many other conditions were trialed in "California Spine Diagnostics" in a lesser frequency.

Most popular intervention types in "California Spine Diagnostics" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BIOSTAT BIOLOGX" (1 trials), "NuQu" (1 trials), "Placebo" (1 trials) and "Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Spine Diagnostics" are 2 trials for "All" genders.

Currently, there are NaN active trials in "California Spine Diagnostics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in California Spine Diagnostics, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in California Spine Diagnostics, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".